Complete Filing Data
Immunocore Holdings plc reported Stockholders Equity of $381.03 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Immunocore Holdings plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$35.5M | -$51.1M | -$55.3M | -$52.5M | -$180.0M | -$74.1M | -$103.9M | -$71.6M |
| Revenue * | $400.0M | $310.2M | $249.4M | $174.4M | $4.1M | |||
| Research And Development Expense | $274.9M | $222.2M | $163.5M | $101.9M | $100.2M | $74.8M | $100.0M | $83.6M |
| Selling General And Administrative Expense | $165.4M | $155.8M | $144.5M | $123.1M | $110.8M | $45.7M | ||
| Other Comprehensive Income Loss Net Of Tax | $5.7M | $2.5M | $18.4M | -$24.4M | -$254.0K | |||
| Other Nonoperating Income Expense | $19.7M | $14.2M | -$897.0K | -$1.7M | -$73.0K | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $5.7M | $2.5M | $18.4M | -$24.4M | -$254.0K | |||
| Operating Income Loss | -$45.4M | -$70.5M | -$59.6M | -$51.7M | -$174.6M | |||
| Income Tax Expense Benefit | $16.4M | -$1.9M | -$5.6M | $11.7M | $150.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$19.1M | -$52.9M | -$60.9M | -$40.9M | -$179.9M | |||
| Cost Of Revenue | $5.1M | $2.7M | $1.0M | $1.1M | $0.00 | |||
| Comprehensive Income Net Of Tax | -$29.8M | -$48.6M | -$36.9M | -$76.9M | -$180.3M | |||
| Interest Expense Nonoperating | $12.2M | $18.8M | $5.2M | $5.4M | ||||
| Income Taxes Paid Net | $4.6M | $510.0K | $977.0K | $765.0K | $17.0M | |||
| Deferred Income Tax Assets Net | $0.00 | $14.8M | $11.0M | $5.1M | ||||
| Revenue From Contracts With Customers | $116.8M | $3.0M | $0.00 | $25.7M | $23.7M | |||
| Revenue | $400.0M | $310.2M | $249.4M | $174.4M | $4.1M | |||
| Profit Loss From Operating Activities | -$39.6M | -$135.2M | -$86.2M | -$118.3M | -$93.5M | |||
| Profit Loss Before Tax | -$44.1M | -$140.9M | -$87.4M | -$126.2M | -$88.2M | |||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$3.2M | -$74.0K | $195.0K | -$99.0K | $72.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$177.0K | -$10.3M | $5.0M | $8.7M | -$11.6M | -$24.4M | $906.0K | -$17.0M | -$19.4M |
| Revenue * | $103.7M | $98.0M | $93.9M | $80.2M | $75.4M | $70.5M | $64.9M | $59.8M | $54.7M |
| Research And Development Expense | $70.6M | $69.0M | $56.5M | $52.8M | $51.1M | $57.5M | $43.2M | $38.2M | $36.6M |
| Selling General And Administrative Expense | $39.8M | $42.8M | $40.2M | $35.5M | $38.6M | $39.3M | $35.5M | $35.0M | $32.6M |
| Other Comprehensive Income Loss Net Of Tax | -$3.4M | $6.5M | $673.0K | $3.2M | $944.0K | $897.0K | -$15.0M | $6.8M | $7.4M |
| Other Nonoperating Income Expense | $5.1M | $4.7M | $5.5M | $9.0M | $4.4M | -$190.0K | -$192.0K | -$190.0K | -$325.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$3.4M | $6.5M | $673.0K | $3.2M | $944.0K | $897.0K | -$15.0M | $6.8M | $7.4M |
| Operating Income Loss | -$7.2M | -$14.9M | -$3.6M | -$8.5M | -$16.0M | -$26.5M | -$14.1M | -$13.8M | -$14.7M |
| Income Tax Expense Benefit | $481.0K | $606.0K | $1.1M | -$2.6M | $1.5M | $357.0K | -$175.0K | $191.0K | $293.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $304.0K | -$9.7M | $6.1M | $6.1M | -$10.1M | -$24.1M | $731.0K | -$16.8M | -$19.2M |
| Cost Of Revenue | $513.0K | $1.0M | $831.0K | $448.0K | $1.7M | $246.0K | $276.0K | $346.0K | $216.0K |
| Comprehensive Income Net Of Tax | -$3.6M | -$3.8M | $5.7M | $12.0M | -$10.7M | -$23.5M | -$14.0M | -$10.2M | -$12.0M |
| Interest Expense Nonoperating | $3.0M | $3.0M | $3.0M | $4.3M | $4.3M | $3.2M | $1.3M | $1.3M | |
| Income Taxes Paid Net | $32.0K | $140.0K | -$220.0K | ||||||
| Deferred Income Tax Assets Net | $14.3M | $14.1M | $14.4M | $12.7M | $10.1M | $10.8M | |||
| Revenue From Contracts With Customers | |||||||||
| Revenue | $103.7M | $98.0M | $93.9M | $80.2M | $75.4M | $70.5M | $64.9M | $59.8M | $54.7M |
| Profit Loss From Operating Activities | |||||||||
| Profit Loss Before Tax | |||||||||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $381.0M | $360.7M | $368.8M | $338.9M | $233.7M | $76.9M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $467.7M | $455.7M | $442.6M | $402.5M | $321.1M | $176.7M | |||
| Liabilities | $686.2M | $648.8M | $228.2M | $187.9M | $130.2M | $141.8M | $170.9M | ||
| Assets | $1.07B | $1.01B | $597.0M | $526.8M | $301.8M | $197.2M | $185.6M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $2.3M | $1.9M | $1.6M | $2.1M | $2.1M | ||||
| Marketable Securities Unrealized Gain Loss | $19.7M | $14.6M | $0.00 | $0.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$14.7M | $14.8M | $31.9M | $94.0M | $143.8M | ||||
| Equity | $381.0M | $360.7M | $368.8M | $338.9M | $233.7M | $76.9M | |||
| Cash And Cash Equivalents | $332.5M | $237.9M | $129.7M | $74.0M | $124.4M | $82.9M | |||
| Operating Lease Right Of Use Asset | $38.8M | $37.6M | $33.5M | $30.9M | |||||
| Retained Earnings Accumulated Deficit | -$831.3M | -$795.8M | -$744.7M | -$689.4M | |||||
| Property Plant And Equipment Net | $11.5M | $10.1M | $9.2M | $7.8M | |||||
| Prepaid Expense And Other Assets Current | $50.1M | $41.0M | $29.6M | $37.2M | |||||
| Other Assets Noncurrent | $20.3M | $17.1M | $14.5M | $8.9M | |||||
| Operating Lease Liability Noncurrent | $41.6M | $40.2M | $35.6M | $31.8M | |||||
| Operating Lease Liability Current | $2.0M | $1.5M | $1.4M | $1.9M | |||||
| Liabilities Current | $246.7M | $212.2M | $139.0M | $100.8M | |||||
| Liabilities And Stockholders Equity | $1.07B | $1.01B | $597.0M | $526.8M | |||||
| Inventory Net | $6.7M | $5.4M | $4.5M | $692.0K | |||||
| Deferred Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | |||||
| Common Stock Value | $136.0K | $135.0K | $134.0K | $129.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $467.7M | $455.7M | $442.6M | $402.5M | |||||
| Assets Current | $996.7M | $929.9M | $528.8M | $474.0M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$28.1M | -$33.8M | -$36.3M | -$54.7M | |||||
| Accrued Liabilities And Other Liabilities | $219.7M | $185.5M | $119.8M | $76.7M | |||||
| Accounts Payable Current | $24.4M | $25.1M | $17.8M | $14.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $396.6M | $388.5M | $378.5M | $377.8M | $359.1M | $359.5M | $356.0M | $351.4M | $341.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $498.4M | $487.9M | $476.8M | $537.8M | $505.0M | $832.8M | $444.1M | $432.0M | $418.4M |
| Liabilities | $705.9M | $693.9M | $649.5M | $706.8M | $664.2M | $634.5M | |||
| Assets | $1.10B | $1.08B | $1.03B | $1.08B | $1.02B | $994.0M | |||
| Operating Lease Right Of Use Asset Amortization Expense | $546.0K | $432.0K | $407.0K | ||||||
| Marketable Securities Unrealized Gain Loss | $5.5M | $0.00 | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $12.7M | $391.0M | $13.7M | ||||||
| Equity | $396.6M | $388.5M | $378.5M | $377.8M | $359.1M | $359.5M | $356.0M | $351.4M | $341.3M |
| Cash And Cash Equivalents | |||||||||
| Operating Lease Right Of Use Asset | $39.4M | $39.4M | $38.1M | $39.7M | $32.4M | $32.8M | |||
| Retained Earnings Accumulated Deficit | -$801.2M | -$801.0M | -$790.7M | -$772.0M | -$780.7M | -$769.1M | |||
| Property Plant And Equipment Net | $9.4M | $9.5M | $9.8M | $9.2M | $7.7M | $8.4M | |||
| Prepaid Expense And Other Assets Current | $49.0M | $44.3M | $41.7M | $36.4M | $33.6M | $31.3M | |||
| Other Assets Noncurrent | $16.5M | $17.0M | $17.1M | $17.2M | $16.3M | $16.0M | |||
| Operating Lease Liability Noncurrent | $41.4M | $42.6M | $40.7M | $41.3M | $33.4M | $34.0M | |||
| Operating Lease Liability Current | $1.9M | $1.8M | $1.7M | $1.1M | $1.4M | $1.2M | |||
| Liabilities Current | $170.4M | $170.1M | $149.2M | $266.2M | $185.1M | $155.3M | |||
| Liabilities And Stockholders Equity | $1.10B | $1.08B | $1.03B | $1.08B | $1.02B | $994.0M | |||
| Inventory Net | $5.7M | $5.5M | $6.8M | $4.5M | $3.5M | $4.2M | |||
| Deferred Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |||
| Common Stock Value | $135.0K | $135.0K | $135.0K | $135.0K | $135.0K | $135.0K | |||
| Cash And Cash Equivalents At Carrying Value | $498.4M | $487.9M | $476.8M | $537.8M | $505.0M | $832.8M | |||
| Assets Current | $1.02B | $1.00B | $948.6M | $1.01B | $956.9M | $926.0M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$30.0M | -$26.6M | -$33.1M | -$31.2M | -$34.4M | -$35.4M | |||
| Accrued Liabilities And Other Liabilities | $144.9M | $143.8M | $118.3M | $197.2M | $163.8M | $138.5M | |||
| Accounts Payable Current | $23.0M | $23.9M | $29.1M | $19.7M | $19.9M | $15.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $37.8M | $34.2M | $32.5M | $32.9M | $48.9M |
| Share Based Compensation | $37.7M | $34.2M | $32.5M | $32.9M | $48.9M |
| Proceeds From Stock Options Exercised | $12.4M | $6.8M | $34.3M | $9.7M | $1.3M |
| Payments To Acquire Property Plant And Equipment | $4.3M | $5.2M | $5.4M | $2.2M | $1.4M |
| Payments Of Debt Issuance Costs | $0.00 | $13.4M | $0.00 | $1.8M | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$10.7M | $26.1M | $2.9M | -$49.2M | -$143.1M |
| Net Cash Provided By Used In Investing Activities | -$16.3M | -$355.1M | -$5.4M | -$2.2M | -$1.3M |
| Net Cash Provided By Used In Financing Activities | $12.4M | $343.9M | $34.3M | $145.4M | $288.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $6.7M | $11.6M | -$8.5M | $14.7M | -$1.4M |
| Increase Decrease In Other Operating Liabilities | $0.00 | $0.00 | -$1.4M | $2.1M | $123.0K |
| Increase Decrease In Other Operating Assets | $6.2M | $4.2M | $9.2M | $4.7M | -$361.0K |
| Increase Decrease In Operating Lease Liability | -$2.1M | -$1.6M | -$2.2M | -$1.8M | -$2.0M |
| Increase Decrease In Accrued Liabilities | $15.9M | $71.5M | $39.1M | $41.8M | $10.7M |
| Increase Decrease In Accounts Receivable | $7.3M | $12.3M | $17.9M | $26.3M | $4.9M |
| Increase Decrease In Accounts Payable | -$2.5M | $7.3M | $2.6M | $4.9M | $1.5M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $26.7M | -$1.7M | $8.3M | -$12.6M | $625.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $9.8M | $10.2M | $9.5M | $6.5M | $10.0M | $9.0M | $8.2M | $8.8M | $8.3M |
| Share Based Compensation | $9.5M | $9.0M | $8.3M | ||||||
| Proceeds From Stock Options Exercised | $2.6M | $5.8M | $6.1M | ||||||
| Payments To Acquire Property Plant And Equipment | $298.0K | $430.0K | $3.0M | ||||||
| Payments Of Debt Issuance Costs | $0.00 | $12.2M | $0.00 | ||||||
| Net Cash Provided By Used In Operating Activities | $435.0K | -$4.6M | $10.5M | ||||||
| Net Cash Provided By Used In Investing Activities | $9.7M | -$430.0K | -$3.0M | ||||||
| Net Cash Provided By Used In Financing Activities | $2.6M | $396.0M | $6.1M | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $28.0K | $1.8M | -$18.1M | ||||||
| Increase Decrease In Other Operating Liabilities | $0.00 | $1.2M | -$453.0K | ||||||
| Increase Decrease In Other Operating Assets | $1.6M | $1.4M | $38.0K | ||||||
| Increase Decrease In Operating Lease Liability | $756.0K | -$490.0K | -$482.0K | ||||||
| Increase Decrease In Accrued Liabilities | -$10.9M | $19.2M | $4.6M | ||||||
| Increase Decrease In Accounts Receivable | -$836.0K | $6.2M | $3.6M | ||||||
| Increase Decrease In Accounts Payable | $3.3M | -$2.3M | -$3.0M | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.4M | -$800.0K | $2.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 50.3M | 50.0M | 48.9M | 45.7M | 42.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 50.3M | 50.0M | 48.9M | 45.7M | 42.5M |
| Earnings Per Share Diluted | $-0.71 | $-1.02 | $-1.13 | $-1.15 | $-4.24 |
| Earnings Per Share Basic | $-0.71 | $-1.02 | $-1.13 | $-1.15 | $-4.24 |
| Deferred Stock Shares Outstanding | 5.8M | 5.8M | 5.8M | 5.8M | |
| Deferred Stock Shares Issued | 5.8M | 5.8M | 5.8M | 5.8M | |
| Deferred Stock Shares Authorized | 5.8M | 5.8M | 5.8M | 5.8M | |
| Common Stock Shares Outstanding | 50.7M | 50.1M | 49.7M | 48.1M | |
| Common Stock Shares Issued | 50.7M | 50.1M | 49.7M | 48.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 50.4M | 50.3M | 50.1M | 50.0M | 50.0M | 49.9M | 49.1M | 48.7M | 48.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 50.4M | 50.3M | 51.9M | 52.8M | 50.0M | 49.9M | 54.2M | 48.7M | 48.2M |
| Earnings Per Share Diluted | $0.00 | $-0.20 | $0.10 | $0.17 | $-0.23 | $-0.49 | $0.02 | $-0.35 | $-0.40 |
| Earnings Per Share Basic | $0.00 | $-0.20 | $0.10 | $0.17 | $-0.23 | $-0.49 | $0.02 | $-0.35 | $-0.40 |
| Deferred Stock Shares Outstanding | 5.8M | 5.8M | 5.8M | 5.8M | 5.8M | 5.8M | |||
| Deferred Stock Shares Issued | 5.8M | 5.8M | 5.8M | 5.8M | 5.8M | 5.8M | |||
| Deferred Stock Shares Authorized | 5.8M | 5.8M | 5.8M | 5.8M | 5.8M | 5.8M | |||
| Common Stock Shares Outstanding | 50.5M | 50.4M | 50.2M | 50.0M | 50.0M | 50.0M | |||
| Common Stock Shares Issued | 50.5M | 50.4M | 50.2M | 50.0M | 50.0M | 50.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $12.4M | $6.3M | $34.3M | $9.7M | $1.3M |
| Investment Income Interest | $16.5M | $25.6M | $18.0M | $3.8M | $65.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $2.2M | -$3.4M | -$13.2M | $14.2M | $289.0K |
| Other Noncash Income Expense | -$2.1M | -$1.8M | -$412.0K | $4.0K | -$222.0K |
| Foreign Currency Transaction Gain Loss Unrealized | $6.4M | -$599.0K | -$13.8M | $14.5M | -$99.0K |
| Depreciation | $3.3M | $4.2M | $4.1M | $5.3M | $7.6M |
| Long Term Notes And Loans | $393.1M | $391.0M | $48.0M | $47.8M | |
| Additional Paid In Capital | $1.24B | $1.19B | $1.15B | $1.08B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.9M | $3.7M | $2.6M | $198.0K | $297.0K | $5.2M | $10.4M | $11.6M | $6.2M |
| Investment Income Interest | $4.1M | $4.3M | $4.2M | $6.0M | $6.2M | $8.2M | $5.1M | $4.3M | $3.1M |
| Foreign Currency Transaction Gain Loss Before Tax | $1.3M | -$738.0K | $3.1M | $4.0M | -$508.0K | -$2.4M | $11.2M | -$5.9M | -$6.0M |
| Other Noncash Income Expense | -$509.0K | $2.0K | $0.00 | ||||||
| Foreign Currency Transaction Gain Loss Unrealized | $2.9M | -$1.3M | -$7.2M | ||||||
| Depreciation | $854.0K | $1.0M | $952.0K | ||||||
| Long Term Notes And Loans | $392.6M | $392.1M | $391.5M | $390.5M | $438.1M | $437.5M | |||
| Additional Paid In Capital | $1.23B | $1.22B | $1.20B | $1.18B | $1.17B | $1.16B |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.